ULORIC
TAKEDA CANADA INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is ULORIC discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that ULORIC 80MG has been permanently discontinued (last updated January 4, 2022). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is ULORIC not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
MAR-FEBUXOSTAT
MARCAN PHARMACEUTICALS INC
FEBUXOSTAT
SANIS HEALTH INC
JAMP FEBUXOSTAT
JAMP PHARMA CORPORATION
M-FEBUXOSTAT
MANTRA PHARMA INC
TEVA-FEBUXOSTAT
TEVA CANADA LIMITED
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02357380
Strength
80MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
FEBUXOSTAT
Tier
Unrated
Last Updated
2022-01-04
Reason for Shortage
Business reasons
Other Products from TAKEDA CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
15MG · DIN 02242572
30MG · DIN 02242573
45MG · DIN 02242574
25MG · DIN 02248812
15MG · DIN 02248810
20MG · DIN 02248811
10MG · DIN 02248809
30MG · DIN 02248813
5MG · DIN 02248808
3000UNIT · DIN 02498626
250UNIT · DIN 02498537
500UNIT · DIN 02498545